Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > A little more information wouldn't be bad!

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 04, 2021 1:07pm

100 Views

Post# 33124201

RE:A little more information wouldn't be bad!

Keep dreaming Charlito. You've been reading too much of the Barron's "Red"oric. They already shat the bed with Sanofi. That is old news and I can assure you there is nothing happening with Sanofi. Sanofi sold their cell line to Evotech. They aren't interested in Sernova. Better line up those massive buys...

Charly50 wrote:
If suddenly there is only silence, then everything is said

But that is not the case, an alliance is actively forged while Canaccord L.J joins the buyers.

Previously, Dr. Azab served as President and CEO of Intradigm Corp., a developer of siRNA cancer therapeutics. Before that, Dr. Azab as Executive Vice President of Research and Development and Chief Medical Officer of QLT Inc. and held various management positions at AstraZeneca in the UK and at S A N O F I Pharmaceuticals in France.

Dr. Schulte is an internationally renowned expert in diabetes, cell therapy and regenerative medicine and has been with us for 19 years

S A N O F I, ...